subject area of
- Does tenofovir influence efavirenz pharmacokinetics? Academic Article
- One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the blt model for evaluation of new microbicide candidates Academic Article
- Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study) Academic Article
- Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices Academic Article